Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities June 27, 2019 - NASDAQ Companies 0 » View More News for June 27, 2019
